
| Company Name | Vara (MX Healthcare GmbH) |
| Founded | 2018 |
| Head office | Berlin, Germany |
| Website | https://www.vara.ai/ |
| Contact | info@vara.ai |
AI-based workflow, Report generation, Safety net, Triaging normal exams
Vara's Decision Referral Pathway ensures that each mammogram is analysed by AI and classified into one of three categories: "normal" (AI is confident there are no suspicious signs), "no classification" (AI is not confident about a classification), or "Safety Net" (AI is confident that it is highly suspicious). Vara pre-screens normal mammograms with very high confidence (pre-fills the report), allowing the reader to focus on potentially suspicious exams. Vara also post-screens mammograms with very high confidence for potentially missed exams (only triggered if the reader assigns BI-RADS <3).
No key features available
Vara Tomosynthesis is software that analyses digital breast tomosynthesis examinations in breast cancer screening. It processes synthetic 2D images, slabs or the full 3D image stack and classifies each examination as unremarkable or suspicious, with regions of interest marked for suspicious findings. According to the manufacturer, it is integrated into the PACS and can be used as a concurrent or independent second reader.